Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rockwell Medical, Inc. (RMTI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.2800-0.0100 (-0.78%)
At close: 04:00PM EDT
1.2600 -0.02 (-1.56%)
After hours: 07:45PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close1.2900
Open1.3000
Bid1.2700 x 800
Ask1.2900 x 900
Day's Range1.2600 - 1.3300
52 Week Range1.2500 - 9.5700
Volume17,606
Avg. Volume65,946
Market Cap12.003M
Beta (5Y Monthly)1.13
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RMTI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rockwell Medical, Inc.
    Daily – Vickers Top Insider Picks for 06/17/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    15 days agoArgus Research
View more
  • Benzinga

    Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate

    Last week, Rockwell Medical Inc (NASDAQ: RMTI) closed the second $7.5 million tranche of the previously announced DaVita Inc (NYSE: DVA) stock purchase agreement of up to $15 million in convertible preferred stock in two tranches. This investment, in addition to the recently announced $15 million financings, brings the total gross amount raised by Rockwell this quarter to $30 million. Related: Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate. The company

  • Benzinga

    Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate

    Rockwell Medical Inc (NASDAQ: RMTI) has provided the FDA with the supplemental data requested by the agency in December 2021 for its pending Investigational New Drug (IND) application of Ferric Pyrophosphate Citrate (FPC) for iron deficiency. The IND supports the proposed Phase 2 trial of FPC for treating iron deficiency anemia and maintaining hemoglobin in patients receiving infusion therapy in the home setting. The additional data relate to the physical, chemical, and microbiological stability

  • Zacks

    Perrigo (PRGO) Q1 Earnings Lag Estimates

    Perrigo (PRGO) delivered earnings and revenue surprises of -21.43% and 1.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Advertisement
Advertisement